# Safety and Immunogenicity of Inactivated Influenza Virus Vaccine Among Healthy Children 6-12 Weeks of Age

> **NCT00242424** · PHASE2,PHASE3 · COMPLETED · sponsor: **Seattle Children's Hospital** · enrollment: 1375 (actual)

## Conditions studied

- Inactivated Influenza Vaccine

## Interventions

- **BIOLOGICAL:** 2005-2006 trivalent inactivated influenza vaccine

## Key facts

- **NCT ID:** NCT00242424
- **Lead sponsor:** Seattle Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2006-09
- **Final completion:** 2007-09
- **Target enrollment:** 1375 (ACTUAL)
- **Last updated:** 2009-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00242424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00242424, "Safety and Immunogenicity of Inactivated Influenza Virus Vaccine Among Healthy Children 6-12 Weeks of Age". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00242424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*